Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on July 28, 2026

Jul. 28, 2026

CISO Global Launches SurfaceWatch™ to Reveal External Cyber Risks Before They Become Incidents

Indeterminate GlobeNewswire

Jul. 28, 2026

AMSC Secures $25 Million Turnkey Contract for Large-Scale Mining Development

Indeterminate GlobeNewswire

Jul. 28, 2026

Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments

Indeterminate GlobeNewswire

Jul. 28, 2026

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 28, 2026

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Indeterminate GlobeNewswire

Jul. 28, 2026

Aligned Data Centers Completes $1.18 Billion Securitization Financing

Indeterminate GlobeNewswire

Jul. 28, 2026

Banzai Announces OpenReel Creator AI: Edit Professional Video by Describing What You Want

Indeterminate GlobeNewswire

Jul. 28, 2026

Sent Raises $12M Series A to Supercharge AI Messaging Infrastructure

Indeterminate GlobeNewswire

Jul. 28, 2026

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Indeterminate GlobeNewswire

Jul. 28, 2026

AirJoule Technologies Deploys AirJoule™ Core System at GE Vernova’s New Advanced Research Center Frontier Campus

Indeterminate GlobeNewswire

Jul. 28, 2026

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Indeterminate GlobeNewswire

Jul. 28, 2026

Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance

Indeterminate GlobeNewswire

Jul. 28, 2026

Trevi Therapeutics to Participate in Upcoming August Conferences

Indeterminate GlobeNewswire

Jul. 28, 2026

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Indeterminate GlobeNewswire

Jul. 28, 2026

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Indeterminate GlobeNewswire

Jul. 28, 2026

ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform

Indeterminate GlobeNewswire

Jul. 28, 2026

Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687

Indeterminate GlobeNewswire

Jul. 28, 2026

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

Indeterminate GlobeNewswire

Jul. 28, 2026

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

Indeterminate GlobeNewswire

Jul. 28, 2026

Lantronix Announces DoD Solution Partnership to Deploy Edge AI Drone Platform in Ukraine

Indeterminate GlobeNewswire